Charles Veltri
Biographic Data
| ID | 9670812 |
|---|---|
| NAME | Charles Veltri |
| GIVEN NAMES | Charles |
| FAMILY NAME | Veltri |
| SIGNATURE | VELTRI C |
| AFFILIATIONS | Midwestern University |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Diversification of Kratom in US Markets
) products in the US have diversified from dried leaf to now include edibles, extracts, teas, and tonics. Higher alkaloid content and/or greater oral exposure across formulations expose consumers to potentially greater amounts of alkaloids per serving in a shorter duration of time, thereby potentially increasing product effect and risk profiles. Six kratom vendors disseminated our anonymous online survey. Participants reported on products use pat…
Current and Future Potential Impact of Covid-19 on Kratom (Mitragyna speciosa Korth.) Supply and Use
Kratom ( Mitragyna speciosa Korth., Rubiaceae) is native to and has traditional use in Southeast Asia. The number of kratom users outside of Southeast Asia has increased significantly in recent decades with use spreading to the Unites States (US) and Europe. Because of its reputed opioid-like psychoactive effects at higher doses, kratom has been regulated in several countries and is subject to an import ban by the US Food and Drug Administration.…
Can Kratom (Mitragyna speciosa) Alleviate Covid-19 Pain? A Case Study
Among the symptoms of COVID-19 fever, general malaise, pain and aches, myalgia, fatigue, and headache can affect the quality of life of patients, even after the end of the acute phase of the infection and can be long lasting. The current treatment of these symptoms, also because COVID-19 patients have been asked not to use non-steroidal anti-inflammatory drugs (NSAIDs), in particular ibuprofen are often unsatisfactory. Among the above mentioned s…
No prominent works on this page.
Current and Future Potential Impact of Covid-19 on Kratom (Mitragyna speciosa Korth.) Supply and Use
Kratom ( Mitragyna speciosa Korth., Rubiaceae) is native to and has traditional use in Southeast Asia. The number of kratom users outside of Southeast Asia has increased significantly in recent decades with use spreading to the Unites States (US) and Europe. Because of its reputed opioid-like psychoactive effects at higher doses, kratom has been regulated in several countries and is subject to an import ban by the US Food and Drug Administration.…
Can Kratom (Mitragyna speciosa) Alleviate Covid-19 Pain? A Case Study
Among the symptoms of COVID-19 fever, general malaise, pain and aches, myalgia, fatigue, and headache can affect the quality of life of patients, even after the end of the acute phase of the infection and can be long lasting. The current treatment of these symptoms, also because COVID-19 patients have been asked not to use non-steroidal anti-inflammatory drugs (NSAIDs), in particular ibuprofen are often unsatisfactory. Among the above mentioned s…
Diversification of Kratom in US Markets
) products in the US have diversified from dried leaf to now include edibles, extracts, teas, and tonics. Higher alkaloid content and/or greater oral exposure across formulations expose consumers to potentially greater amounts of alkaloids per serving in a shorter duration of time, thereby potentially increasing product effect and risk profiles. Six kratom vendors disseminated our anonymous online survey. Participants reported on products use pat…
Alkaloids: synthesis and pharmacology (3 works) · Berberine and alkaloids research (2 works) · Business (2 works) · Coronavirus disease 2019 (COVID-19 (2 works) · Disease (2 works) · Medicine (2 works) · Chemical synthesis and alkaloids (1 work) · Economic shortage (1 work) · Economics (1 work) · Environmental health (1 work)